Nuclease Probe Technologies brings to market an in-field rapid analysis method to test for selected infectious bacteria such as E. coli and S. aureus. The tool kit is rapid and inexpensive for assays that selectively identify bacterial pathogens by detecting unique properties of their nucleases. These assays will have many applications including water and food testing as well as in blood, but mainly as infectious disease diagnostic assays. The technology will detect bacteria in four hours or less, at levels equal to or lower than current methods.

Venture Information
Stage: 
In formation
Industry: 
Diagnostics
Technology or Science Area: 
Diagnostic test kit for the detection of bacterial pathogens
Market: 
Medical therapy and diagnostics market.
Funding Round: 
Seed
Company Information
Founders: 
James McNamara